Neurosense Therapeutics Ltd. (NRSN)
0.3998
-0.02
(-4.38%)
USD |
NASDAQ |
Sep 09, 11:40
Neurosense Therapeutics Max Drawdown (5Y)
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| BioLineRx Ltd. | 98.88% |
| XTL Biopharmaceuticals Ltd. | 90.10% |
| Kamada Ltd. | 67.69% |
| Can-Fite BioPharma Ltd. | 99.43% |
| Galmed Pharmaceuticals Ltd. | 99.94% |